Successful treatment with carfilzomib and dexamethasone for relapsed/refractory POEMS syndrome: a case report and review of literature
We report on the first case of relapsed/refractory POEMS syndrome who received carfilzomib and dexamethasone, and achieved very good remission. Carfilzomib may be a safe and effective treatment option for patients with relapsed/refractory POEMS syndrome.
Authors
- Jun Peng (ORCID: https://orcid.org/0000-0001-5732-4899)
- Luqun Wang
- Shuang Yu (ORCID: https://orcid.org/0000-0001-6565-3019)
- Hao Li (ORCID: https://orcid.org/0000-0003-2832-4851)
- Xiangxin Li (ORCID: https://orcid.org/0000-0001-8249-5489)
Institutions
- Qilu Hospital of Shandong University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-06-06
- DOI
- https://doi.org/10.3389/fonc.2025.1570981
- Citations
- 1
- Primary Topic
- Peripheral Neuropathies and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- Natural Science Foundation of Shandong Province
- Wu Jieping Medical Foundation